Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A double-blind, randomised, cross-over, multi-centre study, to evaluate onset of effect in the morning in patients with severe Chronic Obstructive Pulmonary Disease (COPD) treated with budesonide/formoterol (Symbicort®Turbuhaler®) 320/9 μg, compared with salmeterol/fluticasone (Seretide® Diskus®) 50/500 μg, both given as one inhalation twice daily for one week each https://kusajili.com:443/Trial/Pto0dLn8ukiGb0AfxjDIBA%24a-double-blind-randomised-cross-over-multi-centre-study-to-evaluate-onset-of-effect-in-the-morning-in-patients-with-severe-chro
I have read and accept the terms of use of the site and the Privacy Policy
Send your message